{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:15:49Z","timestamp":1793330149816,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000828","name":"Royal Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000828","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","ajog.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.ajog.2024.03.044","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T03:26:41Z","timestamp":1712460401000},"page":"417-429.e21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis"],"prefix":"10.1016","volume":"231","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5611-1231","authenticated-orcid":false,"given":"Hiba J.","family":"Mustafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enaja V.","family":"Sambatur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"D\u2019Antonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emeline","family":"Maisonneuve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Maurice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien","family":"Zwiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne E.J.T.","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Flood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza A.","family":"Shamshirsaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Jouannic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2024.03.044_bib1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12884-019-2525-y","article-title":"Management and outcome of pregnancies in women with red cell isoimmunization: a 15-year observational study from a tertiary care university hospital","volume":"19","author":"S\u00e1nchez-Dur\u00e1n","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajog.2024.03.044_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.21307\/immunohematology-2019-134","article-title":"Prevalence of clinically significant red blood cell alloantibodies in pregnant women at a large tertiary-care facility","volume":"29","author":"Smith","year":"2013","journal-title":"Immunohematology"},{"key":"10.1016\/j.ajog.2024.03.044_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.siny.2008.02.007","article-title":"Fetal anemia due to non-rhesus-D red-cell alloimmunization","volume":"13","author":"Moise","year":"2008","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2024.03.044_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/uog.3953","article-title":"Middle cerebral artery peak systolic velocity: a new Doppler parameter in the assessment of growth-restricted fetuses","volume":"29","author":"Mari","year":"2007","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2023.10.016","article-title":"Perinatal survival following intrauterine transfusion for red cell alloimmunized pregnancies: systematic review and meta-regression","volume":"230","author":"Donepudi","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000362812","article-title":"Intrauterine blood transfusion: current indications and associated risks","volume":"36","author":"Lindenburg","year":"2014","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2024.03.044_bib7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/uog.17319","article-title":"Complications of intrauterine intravascular blood transfusion: lessons learned after 1678 procedures","volume":"50","author":"Zwiers","year":"2017","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib8","doi-asserted-by":"crossref","first-page":"291.e1","DOI":"10.1016\/j.ajog.2018.06.007","article-title":"Postponing Early intrauterine Transfusion with intravenous immunoglobulin Treatment; the PETIT study on severe hemolytic disease of the fetus and newborn","volume":"219","author":"Zwiers","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib9","article-title":"Effect of intravenous immunoglobulins to postpone the gestational age of first intrauterine transfusion in very severe red blood cell alloimmunization: a case-control study","volume":"50","author":"Maisonneuve","year":"2021","journal-title":"J\u00a0Gynecol Obstet Hum Reprod"},{"key":"10.1016\/j.ajog.2024.03.044_bib10","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/bjh.18449","article-title":"Intravenous immunoglobulin in the management of severe early onset red blood cell alloimmunisation","volume":"200","author":"Vlachodimitropoulou","year":"2023","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2024.03.044_bib11","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S0140-6736(85)92451-1","article-title":"Rhesus haemolytic disease treated with high-dose intravenous immunoglobulin","volume":"1","author":"Berlin","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2024.03.044_bib12","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198802253180816","article-title":"High-dose intravenous immunoglobulin as the sole prenatal treatment for severe Rh immunization","volume":"318","author":"de la C\u00e1mara","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2024.03.044_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/00016349509021196","article-title":"Alloimmunization during pregnancy treated with high dose intravenous immunoglobulin. Effects on fetal hemoglobin concentration and anti-D concentrations in the mother and fetus","volume":"74","author":"Gottvall","year":"1995","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2024.03.044_bib14","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/jca.21705","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice \u2013 evidence-based approach from the writing committee of the American Society for Apheresis: the eighth special issue","volume":"34","author":"Padmanabhan","year":"2019","journal-title":"J\u00a0Clin Apher"},{"key":"10.1016\/j.ajog.2024.03.044_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.ajog.2024.03.044_bib16","first-page":"600","article-title":"Management of rhesus alloimmunization in pregnancy","volume":"100","author":"Moise","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib17","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/1471-0528.17674","article-title":"Severity of haemolytic disease of the fetus and newborn in patients with a history of intrauterine transfusions in a previous pregnancy: a nationwide retrospective cohort study","volume":"131","author":"Van\u2019T Oever","year":"2023","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.03.044_bib18","series-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2014"},{"key":"10.1016\/j.ajog.2024.03.044_bib19","first-page":"4","article-title":"A\u00a0non-invasive treatment option for rhesus D-sensitised women with previous adverse pregnancy outcomes","volume":"26","author":"Frank","year":"2020","journal-title":"Afr J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib20","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/trf.14453","article-title":"Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion","volume":"58","author":"Nwogu","year":"2018","journal-title":"Transfusion"},{"key":"10.1016\/j.ajog.2024.03.044_bib21","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1111\/j.1479-828X.2009.01091.x","article-title":"IVIG \u2013 is it the answer? Maternal administration of immunoglobulin for severe fetal red blood cell alloimmunisation during pregnancy: a case series","volume":"49","author":"Connan","year":"2009","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000111599","article-title":"Early intraperitoneal Transfusion and Adjuvant Maternal Immunoglobulin Therapy in the Treatment of Severe Red\u00a0Cell alloimmunization prior to Fetal Intravascular Transfusion","volume":"23","author":"Fox","year":"2008","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2024.03.044_bib23","doi-asserted-by":"crossref","first-page":"138.e1","DOI":"10.1016\/j.ajog.2006.10.890","article-title":"Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization","volume":"196","author":"Ruma","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib24","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1080\/00016340802268880","article-title":"Alloimmunization in pregnancy during the years 1992\u20132005 in the central west region of Sweden","volume":"87","author":"Gottvall","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2024.03.044_bib25","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/uog.7696","article-title":"Early intrauterine transfusion in severe red blood cell alloimmunization","volume":"36","author":"Yinon","year":"2010","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2024.03.044_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.5144\/0256-4947.2021.313","article-title":"Complications of intravascular intrauterine transfusion for Rh alloimmunization","volume":"41","author":"Alkhaibary","year":"2021","journal-title":"Ann Saudi Med"},{"key":"10.1016\/j.ajog.2024.03.044_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1159\/000328683","article-title":"Procedure-related complications and perinatal outcome after intrauterine transfusions in red cell alloimmunization in Stockholm","volume":"30","author":"Tiblad","year":"2011","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.ajog.2024.03.044_bib28","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/985646","article-title":"IgG placental transfer in healthy and pathological pregnancies","volume":"2012","author":"Palmeira","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.ajog.2024.03.044_bib29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/bjh.17041","article-title":"Medical therapy to attenuate fetal anaemia in severe maternal red cell alloimmunisation","volume":"192","author":"Castleman","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajog.2024.03.044_bib30","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jaip.2013.09.012","article-title":"Adverse effects of IgG therapy","volume":"1","author":"Berger","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.ajog.2024.03.044_bib31","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/trf.13779","article-title":"Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopenia","volume":"56","author":"Lakkaraja","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.ajog.2024.03.044_bib32","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pd.5355","article-title":"The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization","volume":"38","author":"Zwiers","year":"2018","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2024.03.044_bib33","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1471-0528.12063","article-title":"Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation","volume":"120","author":"Lindenburg","year":"2013","journal-title":"BJOG"},{"key":"10.1016\/j.ajog.2024.03.044_bib34","first-page":"703","article-title":"High-dose intravenous gamma globulin: does it have a role in the treatment of severe erythroblastosis fetalis?","volume":"76","author":"Chitkara","year":"1990","journal-title":"Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824005088?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937824005088?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T13:44:53Z","timestamp":1726580693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937824005088"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0002937824005088"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2024.03.044","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravenous immunoglobulin for the treatment of severe maternal alloimmunization: individual patient data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2024.03.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}